PEOPLE - Inovio (Norway) makes appointment:
This article was originally published in Clinica
Executive Summary
Inovio (Oslo, Norway), a biotechnology company specialising in the development and use of electroporation-based drug delivery systems for in vivo delivery of genes and other biomolecules, has appointed David Pyrce as chief business officer. Mr Pyrce, who has over 25 years of senior management experience in the healthcare industry, most recently served as vice-president of corporate development at biopharmaceutical company Vical.